Clinical Trials Browser

Unknown × Immunoglobulin Light-chain Amyloidosis × daratumumab × Clear all

NCT04474938 2022-05-10

Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis

Phase 2 Unknown

Immunoglobulin Light-chain Amyloidosis